| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Jan―04 |
Kounis syndrome associated with remdesivir therapy in a COVID-19 patient |
Eirini Beneki, Kyriakos Dimitriadis, Alexandros Antonopoulos, Konstantina Aggeli, Konstantinos Tsioufis |
| 2 |
[GO] |
2023―Sep―19 |
Outcomes of pediatric ingestions of alcohol-based hand sanitizers during the COVID-19 pandemic |
Justin Corcoran, Ryan Feldman, Jillian Theobald |
| 3 |
[GO] |
2023―Jun―09 |
Clinical features of COVID-19 rapid antigen test exposures reported by an Australian poisons information centre: a prospective study |
Katherine Chiew, Nicole E. Wright, Rose Cairns |
| 4 |
[GO] |
2023―Mar―09 |
Trends in pediatric nonprescription analgesic/antipyretic exposures during the COVID-19 pandemic |
Sara Karami, Cooma Asonye, Ellen Pinnow, Valerie Pratt, Lynda McCulley, Nana Dwumfour, Esther H. Zhou |
| 5 |
[GO] |
2022―Dec―02 |
An observational study of adverse drug reactions to COVID-19 vaccines reported to the New Mexico poison center hotline |
Yomi Tadfor, Ngan Nguyen-Hua, Hillary Bennett, Alexander J. Bos, Susan C. Smolinske |
| 6 |
[GO] |
2022―Nov―28 |
Pediatric poison exposures reported to United States poison centers before and during the COVID-19 pandemic |
Hailee R. Ciccotti, Henry A. Spiller, Marcel J. Casavant, Sandhya Kistamgari, Alexandra R. Funk, Gary A. Smith |
| 7 |
[GO] |
2022―Nov―14 |
Characteristics of ivermectin toxicity in patients taking veterinary and human formulations for the prevention and treatment of COVID-19 |
Ruby Hoang, Courtney Temple, Matthew S. Correia, Joseph Clemons, Robert G. Hendrickson |
| 8 |
[GO] |
2022―Sep―21 |
Effect of the first wave of COVID-19 on Poison Control Centre activities in 21 European countries: an EAPCCT initiative |
L. Hondebrink, M. Zammit, L. C. G. Høgberg, M. Hermanns-Clausen, D. Lonati, K. Faber |
| 9 |
[GO] |
2022―May―10 |
Ivermectin associated adverse events in the treatment and prevention of COVID-19 reported to the FACT pharmacovigilance project |
Rita Farah, Ziad Kazzi, Jeffrey Brent, Keith Burkhart, Paul Wax, Kim Aldy |
| 10 |
[GO] |
2022―Apr―26 |
Changes in unintentional cannabis exposures in children 6 months to 5 years reported to United States poison centers during the first nine months of the coronavirus-19 pandemic |
Thomas W. Laudone, James B. Leonard, Elizabeth Quaal Hines, Hyunuk Seung, Wendy Klein-Schwartz |
| 11 |
[GO] |
2022―Apr―01 |
Fluvoxamine used to treat COVID-19 resulting in theophylline toxicity from CYP 1A2 drug-drug interaction |
Jon B. Cole, Rebecca B. Meiners, Stacey A. Bangh |
| 12 |
[GO] |
2022―Feb―03 |
Exposure to hand sanitisers and other cleaning products in Victoria, Australia during the COVID-19 pandemic |
Alice Norvill, Rohan A. Elliott, Anselm Wong |
| 13 |
[GO] |
2021―Dec―14 |
COVID-19 lockdowns and incidence of psychoactive substance exposure according to age and sex |
Aurélien Spinelli, Theo Willeman, Matthieu Roustit, Françoise Stanke-Labesque |
| 14 |
[GO] |
2021―Dec―06 |
Changes in California cannabis exposures following recreational legalization and the COVID-19 pandemic |
Winter Roth, Mitchell Tam, Carrie Bi, June Kim, Justin Lewis, Raymond Ho, Dorie E. Apollonio |
| 15 |
[GO] |
2021―Aug―27 |
Making US poison centers a part of the solution to the COVID-19 pandemic |
Daniel A. Spyker, Alvin C. Bronstein, Julie A. Weber |
| 16 |
[GO] |
2021―Aug―17 |
An outbreak of mushroom poisoning in Israel during the 2020 fall and winter season: an unexpected outcome of COVID-19 restrictions? |
Yael Lurie, Dalia Lewinsohn, Daniel Kurnik |
| 17 |
[GO] |
2021―May―14 |
Hospital encounters for pediatric ingestions before and during the COVID-19 pandemic |
Brian R. E. Schultz, Jennifer A. Hoffmann, Cathleen Clancy, Sriram Ramgopal |
| 18 |
[GO] |
2021―Mar―31 |
The Poison Center as a pandemic response: establishment and characteristics of a COVID-19 hotline through the New Jersey Poison Center |
Christopher W. Meaden, Christine Ramdin, Bruce Ruck, Lewis S. Nelson, Chloe Soukas, Mitchell Hirsch, et al. (+3) Peter Alsharif, David Beckford, Diane P. Calello |
| 19 |
[GO] |
2021―Mar―26 |
Toxicity resulting from colchicine used to treat COVID-19 patients: a new challenge for clinical toxicologists |
Azzurra Schicchi, Bruno Mégarbane |
| 20 |
[GO] |
2021―Mar―23 |
Death by hand sanitizer: syndemic methanol poisoning in the age of COVID-19 |
Sarah Denise Holzman, Jaiva Larsen, Ramandeep Kaur, Geoffrey Smelski, Steven Dudley, Farshad Mazda Shirazi |
| 21 |
[GO] |
2021―Mar―01 |
Safety and effectiveness concerns of lopinavir/ritonavir in COVID-19 affected patients: a retrospective series |
Marc-Antoine Lepage, Nicholas Rozza, Richard Kremer, Ami Grunbaum |
| 22 |
[GO] |
2021―Feb―19 |
COVID-19 and contamination: impact on exposures to alcohol-based hand sanitizers reported to Texas Poison Control Centers, 2020 |
Todd Phillips, Joann M. Schulte, Eric Anthony Smith, Brett Roth, Kurt C. Kleinschmidt |
| 23 |
[GO] |
2021―Feb―17 |
Poisoning during the COVID-19 outbreak and lockdown: retrospective analysis of exposures reported to French poison control centres |
Gaël Le Roux, Sandra Sinno-Tellier, Emmanuel Puskarczyk, Magali Labadie, Katharina von Fabeck, Fanny Pélissier, et al. (+4) Patrick Nisse, Nathalie Paret, Alexis Descatha, Dominique Vodovar |
| 24 |
[GO] |
2021―Jan―04 |
Modifying triage protocols for poisoned patients during the COVID-19 pandemic to contribute to preservation of healthcare capacity: early experience of the New Zealand National Poisons Centre |
Adam C. Pomerleau, Robin Slaughter, Eeva-Katri Kumpula |
| 25 |
[GO] |
2020―Nov―16 |
Evaluating the impact of home quarantine during the coronavirus pandemic on pediatric exploratory ingestions |
Michael Levine, Alicia Minns, Sam Ontiveros, Stephen H. Thomas, F. Lee Cantrell |
| 26 |
[GO] |
2020―Sep―09 |
Geospatial correlation between COVID-19 health misinformation and poisoning with household cleaners in the Greater Boston Area |
Michael A. Chary, Daniel L. Overbeek, Alexandria Papadimoulis, Adina Sheroff, Michele M. Burns |
| 27 |
[GO] |
2020―Sep―08 |
Response to Comment on “Truncated IV acetylcysteine treatment duration has potential to safely preserve resources during the COVID-19 pandemic” |
Robert Goodnough, Karla Canseco |
| 28 |
[GO] |
2020―Sep―01 |
Comment on “Truncated IV acetylcysteine treatment duration has potential to safely preserve resources during the COVID-19 pandemic.” |
Anselm Wong |
| 29 |
[GO] |
2020―Aug―27 |
Alcohol-based hand sanitizer exposures and effects on young children in the U.S. during the COVID-19 pandemic |
Lynda McCulley, Carmen Cheng, Evelyn Mentari, Ida-Lina Diak, Theresa Michele |
| 30 |
[GO] |
2020―Aug―04 |
Fatal ingestion of sodium chlorite used as hand sanitizer during the COVID-19 pandemic |
Jacob A. Lebin, Anita Ma, Anita Mudan, Craig G. Smollin |
| 31 |
[GO] |
2020―Apr―29 |
Truncated IV acetylcysteine treatment duration has potential to safely preserve resources during the COVID-19 pandemic |
Robert Goodnough, Karla Canseco |
| 32 |
[GO] |
2020―Apr―02 |
Chloroquine and hydroxychloroquine to treat COVID-19: between hope and caution |
Bruno Mégarbane |
